The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors

por Ko, Tun Kiat, Chuah, Charles T.H., Huang, John W.J., Ng, King-Pan, Ong, S. Tiong
Publicado 2014

Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia

por Soh, Sheila Xinxuan, Lim, Joshua Yew Suang, Huang, John W. J., Jiang, Nan, Yeoh, Allen Eng Juh, Ong, S. Tiong
Publicado 2014

The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia

por Ko, Tun Kiat, Chin, Hui San, Chuah, Charles T.H., Huang, John W.J., Ng, King-Pan, Khaw, Seong Lin, Huang, David C.S., Ong, S. Tiong
Publicado 2015